97160 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons; Interleukins [IL] IL-1
Arthritis Treatment
#302Antigen binding polypeptides
#303IL-1 binding proteins
#304METHOD FOR THE TREATMENT OF GOUT OR PSEUDOGOUT
#305Antibodies to human IL-1β
#306Antibody Formulation
#307METHODS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
#308Biological products
#309Methods of treating diabetes using IL-1beta antibodies
#310Humanized antibodies
#311IL-1 BINDING PROTEINS
#312USES OF IL-22, IL-17, AND IL-1 FAMILY CYTOKINES IN AUTOIMMUNE DISEASES
#313IL-1 binding proteins
#314Dual variable domain immunoglobulins and uses thereof
#315Method for administering homeopathically potentiated antibodies against mediator of inflammation
#316Methods for the treatment of IL-1β related diseases
#317Antigen binding polypeptides
#318CARDIOVASCULAR RELATED USES OF IL-1BETA ANTIBODIES AND BINDING FRAGMENTS THEREOF
#319Methods for the treatment of IL-1β related diseases
#320MEDICAL SHARPS AND WASTE DISPOSAL CONTAINER AND METHOD OF MAKING THE SAME
#321Dual specificity antibody fusions
#322Method of treating disorders of the cardiovascular system and a pharmaceutical agent
#323Rationale for IL-1 Beta targeted therapy in sickle cell disease for ischemia-reperfusion induced complications
#324Homogeneous Antibody Populations
#325Method of treating a pathological syndrome and a pharmaceutical agent
#326IL-1 binding proteins
#327Method of treating a disorder or condition of viral etiology
#328Antibodies against interleukin-1 β
#329Method for administering homeopathically potentized antibody
#330Method of treating an auto-inflammatory syndrome with a human IL-1β binding antibody
#331Method of treating inflammation by administering human IL-1B antibodies
#332Use of an antibody that blocks TNF-alpha activity for treating a nerve disorder mediated by nucleus pulposus
#333Compositions and methods for the systemic treatment of arthritis
#334Modulation of the amount or function of pathogenic CD14+CD16+ monocytes
#335Compositions and methods for the systemic treatment of arthritis
#336IL-1β binding antibodies and fragments thereof
#337Method of treating an IL-1 related coronary condition
#338IL-1 ZETA, IL-1 ZETA SPLICE VARIANTS AND XREC2 DNAS AND POLYPEPTIDES
#339Dual variable domain immunoglobulin and uses thereof
#340USE OF ORGANIC COMPOUNDS
#341TREATMENT OF CANCER WITH ANTI-IL-1alpha ANTIBODIES
#342TREATING DIABETES USING INHIBITORS OF IL-1
#343Dual variable domain immunoglobulins and uses thereof
#344Dual variable domain immunoglobulins and uses thereof
#345Interleukin-1α antibodies
#346Dual-specific IL-1α/IL-1β antibodies
#347IL-1β binding antibodies and binding fragments thereof
#348ANTIBODIES TO HUMAN IL-1BETA
#349Dual specificity antibodies and methods of making and using
#350IL1-β Binding antibodies and fragments thereof
#351Dual variable domain immunoglobulin and uses thereof
#352Method of treating an IL-1 related autoimmune disease or condition
#353Method of treating an IL-1 related cancer
#354Humanized anti-IL-1 beta antibodies
#355IL-1alpha IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS
#356Methods for the treatment of gout
#357Method and composition for treatment of renal failure with antibodies and their equivalents as partial or complete replacement for dialysis
#358Antibodies to human IL-1β
#359Method of treatment using a cytokine able to bind IL-18BP to inhibit the activity of a second cytokine
#360Method of treating an IL-1 related inflammatory disease or condition
#361Method of treating or preventing an IL-1 related disease or condition
#362METHOD FOR THE TREATMENT OF GOUT OR PSEUDOGOUT
#363Methods for the treatment of IL-1β related diseases
#364Methods of treating arthritis using IL-1β binding molecules
#365Immuno-Adsorbers For Treatment of Inflammations
#366Human IL-1 epsilon DNA and polypeptides
#367IL-1F6 polypeptides
#368Compositions and Methods for the Systemic Treatment of Arthritis
#369Compositions and Methods for the Systemic Treatment of Arthritis
#370Compositions and methods for the systemic treatment of arthritis
#371Method of treating a pathological syndrome and a pharmaceutical agent
#372Method of treating a pathological syndrome and a pharmaceutical agent
#373Method of treating a pathological syndrome and a pharmaceutical agent
#374IL-1β binding antibodies and fragments thereof
#375Method of treating a pathological syndrome and a pharmaceutical agent
#376Method of treating a pathological syndrome and a pharmaceutical agent
#377Specific TNF-A inhibitors for treating spinal disorders mediated by nucleous pulposus
#378Methods of targeting multiple cytokines
#379Methods of decreasing vascular calcification using IL-1 inhibitors
#380Method of treating a pathological syndrome and a pharmaceutical agent
#381Method and composition for treatment of renal failure with antibodies and their equivalents as partial or complete replacement for dialysis
#382IL-1 zeta splice variant polypeptide
#383METHOD FOR THE TREATMENT OF GOUT OR PSEUDOGOUT
#384Use of TNF-alpha inhibitors for treating a nerve disorder mediated by nucleus pulposus
#385Dual variable domain immunoglobulin and uses thereof
#386Antibodies against interleukin-1β
#387Methods for obtaining antibodies
#388Antibodies to human IL-1β
#389Antibody molecules having specificity for human IL-1β
#390Assay for identifying antibody producing cells
#391Humanized anti-IL-1β antibodies
#392Treatment of acne
#393Methods of treating inflammatory and/or autoimmune disease
#394Compositions and methods for the systemic treatment of arthritis
#395IL1-β: a new target for myeloma therapy
#396Screening method for antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof
#397Interleukin-1 beta antibodies
#398Anti-interleukin-1 beta analogs
#399IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAs and polypeptides
#400IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAs and polypeptides
#401IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAS and polypeptides
#402Polynucleotide encoding IL-1 zeta, TDZ.1 isoform polypeptide